These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8972305)

  • 1. Haemoglobin adducts of N-nitroso compounds.
    Richter E
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():115-9. PubMed ID: 8972305
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA damage studies related to the assessment of the role of N-nitroso compounds in human cancer.
    Kyrtopoulos SA; Souliotis VL; Chhabra SK; Anderson LM
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():109-14. PubMed ID: 8972304
    [No Abstract]   [Full Text] [Related]  

  • 3. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
    Baird WM; Mahadevan B
    Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experimental basis for the role of nitroso compounds in human cancer.
    Magee PN
    Cancer Surv; 1989; 8(2):207-39. PubMed ID: 2696578
    [No Abstract]   [Full Text] [Related]  

  • 5. Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview.
    Bartsch H; Spiegelhalder B
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():11-7. PubMed ID: 8972287
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of action of N-nitroso compounds.
    Archer MC
    Cancer Surv; 1989; 8(2):241-50. PubMed ID: 2696579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids.
    Hecht SS; Hoffman D
    Eur J Cancer Prev; 1998 Jun; 7(3):244-6. PubMed ID: 9696933
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinogen-DNA adducts as a biomarker for cancer risk.
    Rundle A
    Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
    Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
    Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adducts in mammalian cells as indicators of exposure to carcinogens.
    Shuker DE
    IARC Sci Publ; 1999; (146):287-308. PubMed ID: 10353392
    [No Abstract]   [Full Text] [Related]  

  • 11. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Dingley KH; Curtis KD; Nowell S; Felton JS; Lang NP; Turteltaub KW
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):507-12. PubMed ID: 10385140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology relating N-nitroso compounds to human cancer.
    Caygill CP
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():125-30. PubMed ID: 8972307
    [No Abstract]   [Full Text] [Related]  

  • 14. N-nitroso compounds, their relevance to human cancer and further prospects for prevention.
    Reed PI
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():137-47. PubMed ID: 8972309
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology.
    Wild CP; Pisani P
    IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-nitroso compounds: occurrence, biological effects and relevance to human cancer. Proceedings of the VIIIth International Symposium on N-Nitroso Compounds. Banff, Canada, 5-9 September 1983.
    IARC Sci Publ; 1984; (57):1-1011. PubMed ID: 6532997
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.
    Shibutani S; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
    Chem Res Toxicol; 1999 Jul; 12(7):646-53. PubMed ID: 10409405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence re: Czene et al., Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epidemiol. Biomark. Prev., 11: 315-318, 2002.
    Albertini RJ
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):388; author reply 388-9. PubMed ID: 12692119
    [No Abstract]   [Full Text] [Related]  

  • 19. [Markers of the formation of carcinogenic nitroso compounds].
    Rubenchik BL
    Vopr Onkol; 1987; 33(7):3-9. PubMed ID: 3303683
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of DNA adducts in smoking-related carcinogenesis].
    Schoket B
    Magy Onkol; 2004; 48(3):201-5. PubMed ID: 15520869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.